Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells
about
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advancesThe development and application of a quantitative peptide microarray based approach to protein interaction domain specificity spaceInvolvement of protein tyrosine phosphatases in adipogenesis: new anti-obesity targets?Regulation of vascular smooth muscle phenotype by cross-regulation of krüppel-like factorsThe role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation.Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.Cellular and Molecular Mechanisms of Phenotypic Switch in Gastrointestinal Smooth Muscle.P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectinSmooth muscle cell signal transduction: implications of vascular biology for vascular surgeons.The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acidTIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation.Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to folThe influence of RGD-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype.β-Adrenergic Receptor and Insulin Resistance in the Heart.Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance.Nuclear import mechanism for myocardin family members and their correlation with vascular smooth muscle cell phenotype.Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors.Endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress.
P2860
Q21131281-A820F2F7-6D4F-43DE-87F0-CB764BBC9068Q24563332-341D4171-8899-4C65-9212-568199D588E9Q26827352-FB465D31-FA1A-43F4-9EDB-95CCCEA6B209Q30354532-49E525A2-5FD9-435C-9C5A-2E1D00B45FAFQ33577586-5821B7D1-23BD-468C-820E-9D545E8C370BQ33855046-F3ACEDCE-6860-423B-A29D-9B54B36365ACQ34146262-7A90BDAD-58ED-4EA7-9035-05804DB01E23Q34966603-5C9B5E02-A20F-4EF9-A616-4D3E4F06D0CCQ35055601-55D72183-A7DC-4C69-93CF-426BC8DEE756Q35640301-F334D130-3570-4076-A720-99935484F467Q35709811-85B3CEF3-170D-41F7-87AF-C25F0EE3ED6EQ35754163-515C99FB-2722-432B-AA6A-39BA959BE2D2Q35925223-D14E2A10-A6C2-454B-8FBC-CE0396DF77E8Q36246905-F9A4D750-ABA2-4380-992D-10CF1A6C8B47Q36654406-316D69C7-27CD-4E59-ACFC-E9D6B8FD45EFQ36862768-CFEE36A2-D484-4F50-B8D7-9E2CCA03FFBCQ36870887-86C8555C-C677-44A9-8F76-D9C039BDD816Q37106652-A330C6EC-0FD7-42C5-8D74-7B9F0049491EQ37328039-0FB5BBFB-C37D-4D4B-B7FB-4F8152A5EB2AQ37551918-5C277859-4D62-4313-80A5-336B4B1AE064Q37837732-41026A61-753C-4072-98D9-C213612D6B87Q37865381-74A127E7-8F74-46F3-86E0-D592DAA039BBQ38165106-41E52D3F-4A0C-45A3-9F36-DC8EEC378A56Q41714511-298937F6-4A35-4942-9D66-BAF224017150Q46972339-35899671-3FAE-45BE-8F37-88730D8ED56AQ51158859-F3AFA344-5DFC-41A9-968D-C7FEE45959D4Q54466508-63135C0E-17B5-444A-A28D-2B426C4A9AE0
P2860
Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells
description
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im September 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/09/24)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/09/24)
@nl
наукова стаття, опублікована у вересні 2004
@uk
name
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@ast
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@en
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@nl
type
label
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@ast
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@en
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@nl
prefLabel
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@ast
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@en
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@nl
P2093
P2860
P356
P1476
Insulin receptor substrate-1/S ...... n vascular smooth muscle cells
@en
P2093
Katsushi Shibata
Kazuhiro Iwasaki
Ken'ichiro Hayashi
Kenji Sobue
Masahiro Watanabe
Tsuyoshi Morita
P2860
P304
40807–40818
P356
10.1074/JBC.M405100200
P407
P577
2004-09-24T00:00:00Z